All Insights
Showing 241 - 252 of 390
Life Sciences and Healthcare
Health data leak: 1.5 million euro fine against Dedalus Biologie
Following a massive health data leak disclosed in the press concerning nearly 500,000 persons in February 2021, the French Authority
Life Sciences and Healthcare
Italy is finally poised to get a law on transparency in the healthcare sector
Sunshine Act will oblige Italian pharmas to respect the obligations of transparency regardless of industry codes The Italian Parliament is
Life Sciences and Healthcare
The transfer of Data of non-profit clinical trials to pharmaceutical companies is now allowed in Italy
Previous restrictions on data transfer are lifted, enabling more investment - some clarification on practical issues is awaited In the
Life Sciences and Healthcare
Compassionate Use in Europe
As European countries implement compassionate use programmes in different ways, we offer a guide to the different approaches taken within
Intellectual property
European Commission proposes harmonisation of patent law with unitary SPCs and single procedure for grant
The European Commission has launched a call for evidence on its proposal to create a unitary supplementary protection certificate and/or
Life Sciences and Healthcare
Farmindustria releases updated Code Of Ethics
Italy's association for pharmaceutical companies has amended its Code of Ethics with 4 new articles on PSP and on the
Life Sciences and Healthcare
Is Italy's new law on rare diseases a starting or end point?
Pharmaceutical companies will need to take note of new rules that include funding for research and tax incentives After a
Intellectual property
Vagisil versus Vagisan and prefixes: takeaways for healthcare brand owners
Vagisan was found by the High Court to infringe the Vagisil trade mark and a proposed rebrand to 'Dr Wolff's
Life Sciences and Healthcare
Government set to introduce new legislation to facilitate gene editing in plants
The UK wants genetic technologies used for agricultural innovation, but the commercial path and patent position remain unclear
Life Sciences and Healthcare
2021 Life Sciences Patent Case Review
The UK Patents court has had an active year – we review 18 of the principal cases for the sector
Life Sciences and Healthcare
Medical device advertising in Italy: is authorisation by the Ministry of Health still required?
Italian Ministry of Health departs from harmonised EU regulatory framework on advertising medical devices by continuing authorisation regime
Life Sciences and Healthcare
Patient support programs: comments on Royal Decree 957/2020
Should patient support programs meet the requirements provided for non-interventional studies? Despite its brief regulation, patient support programs sparked debate
